LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Strona główna・Stock List・Collegium Pharmaceutical Inc

C
Collegium Pharmaceutical Inc

Closed

SectorHealthcare

48.36 -0.49

Buy Sell

Overview

Share price change

24h

Current

Min

47.97

Max

49.01

Key metrics
By Trading Economics
Income	20M 32M
Sales	21M 209M
P/E Sector Avg	29.393 77.671
Profit margin	15.049
Employees	357
EBITDA	28M 122M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+2.33% upside

Market Stats
By TradingEconomics
Market Cap	377M 1.5B
Previous open	48.85
Previous close	48.36

News Sentiment

By Acuity

24%

76%

75 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

27.09 / 27.6 Support & Resistance

Collegium Pharmaceutical Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 gru 2025, 22:02 UTC

Earnings

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 gru 2025, 21:46 UTC

Earnings

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 gru 2025, 23:52 UTC

Acquisitions, Mergers, Takeovers

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 gru 2025, 23:43 UTC

Market Talk

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 gru 2025, 23:36 UTC

Market Talk

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 gru 2025, 23:20 UTC

Earnings

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 gru 2025, 23:15 UTC

Earnings

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 gru 2025, 22:59 UTC

Market Talk

Earnings

Acquisitions, Mergers, Takeovers

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 gru 2025, 22:45 UTC

Market Talk

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 gru 2025, 22:40 UTC

Earnings

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 gru 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 gru 2025, 22:06 UTC

Earnings

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 gru 2025, 22:02 UTC

Earnings

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 gru 2025, 22:00 UTC

Earnings

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 gru 2025, 21:53 UTC

Earnings

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 gru 2025, 21:50 UTC

Acquisitions, Mergers, Takeovers

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 gru 2025, 21:50 UTC

Market Talk

Earnings

Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

10 gru 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 gru 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 gru 2025, 21:45 UTC

Acquisitions, Mergers, Takeovers

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 gru 2025, 21:33 UTC

Earnings

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 gru 2025, 21:32 UTC

Earnings

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 gru 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 gru 2025, 21:25 UTC

Earnings

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 gru 2025, 21:18 UTC

Acquisitions, Mergers, Takeovers

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 gru 2025, 21:16 UTC

Earnings

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 gru 2025, 21:15 UTC

Acquisitions, Mergers, Takeovers

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 gru 2025, 21:15 UTC

Earnings

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 gru 2025, 21:14 UTC

Earnings

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 gru 2025, 21:14 UTC

Earnings

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Peer Comparison

Price change

Collegium Pharmaceutical Inc Forecast

Price Target

By TipRanks

2.33% upside

12 Months Forecast

Average 50 USD 2.33%

High 58 USD

Low 46 USD

Based on 4 Wall Street analysts offering 12 month price targets forCollegium Pharmaceutical Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

Buy

Hold

Sell

Based on 4 analysts giving stock ratings to Collegium Pharmaceutical Inc - Dist in the past 3 months.

Technical Score

By Trading Central

27.09 / 27.6Support & Resistance

Bullish events outweigh bearish events.

The bullish and bearish events are balanced.

All events are bearish.

Sentiment

By Acuity

75 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.